Cargando…
Apelin-13 Pretreatment Promotes the Cardioprotective Effect of Mesenchymal Stem Cells against Myocardial Infarction by Improving Their Survival
Although mesenchymal stem cell- (MSC-) based therapy has shown promising results for myocardial infarction (MI), low cell survival heavily limits its beneficial effects. Apelin plays an essential regulatory role in cell proliferation. This study was aimed at determining whether Apelin-13 pretreatmen...
Autores principales: | Chen, Guona, Liang, Xiaoting, Han, Qian, Mai, Cong, Shi, Linli, Shao, Zhuang, Hong, Yimei, Lin, Fang, Li, Mimi, Hu, Bei, Li, Xin, Zhang, Yuelin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960019/ https://www.ncbi.nlm.nih.gov/pubmed/35355588 http://dx.doi.org/10.1155/2022/3742678 |
Ejemplares similares
-
Hemin enhances the cardioprotective effects of mesenchymal stem cell-derived exosomes against infarction via amelioration of cardiomyocyte senescence
por: Zheng, Huifeng, et al.
Publicado: (2021) -
Apelin Rejuvenates Aged Human Mesenchymal Stem Cells by Regulating Autophagy and Improves Cardiac Protection After Infarction
por: Zhang, Hao, et al.
Publicado: (2021) -
miR‐155‐5p inhibition rejuvenates aged mesenchymal stem cells and enhances cardioprotection following infarction
por: Hong, Yimei, et al.
Publicado: (2020) -
Myocardial impact and cardioprotective effects of apelin-13 and a c-terminal-modified analog during lps and clp experimental sepsis
por: Lesur, O
Publicado: (2015) -
Mesenchymal Stem Cell-Based Therapy for Stroke: Current Understanding and Challenges
por: Li, Weifeng, et al.
Publicado: (2021)